Wealthcare Advisory Partners’s IGC Pharma IGC Stock Holding History

Wealthcare Advisory Partners’s Portfolio IGC Stock Details IGC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.72K	Hold	10,000	–	–	﹤0.01%	1083
2026 Q1	$2.63K	Buy	+10,000	New	+$2.77K	﹤0.01%	1073

Other funds holding IGC

Lawood & Co Williamsport, Pennsylvania $148M AUM

FFA

Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return

TCM

Triumph Capital Management Denver, Colorado $552M AUM 20.75% 1-Year Est. Return

Wealthcare Advisory Partners's IGC Position: Q2 2026 in Review

Wealthcare Advisory Partners held its IGC Pharma (IGC) position steady in Q2 2026 at 10,000 shares worth $2.72K. The position accounts for ﹤0.01% of the portfolio, ranked #1083.

Wealthcare Advisory Partners first reported a position in IGC in Q1 2026 and has held it in 2 quarters since. 4 funds tracked by Wall St. Rank hold IGC as of Q2 2026.

Wealthcare Advisory Partners held 10,000 shares of IGC Pharma worth $2.72K as of Q2 2026.
Wealthcare Advisory Partners left its IGC Pharma share count unchanged in Q2 2026.
IGC Pharma made up ﹤0.01% of Wealthcare Advisory Partners's portfolio in Q2 2026, its #1083 holding.
Wealthcare Advisory Partners first reported a position in IGC Pharma in Q1 2026 and has held it in 2 quarters since.
4 funds tracked by Wall St. Rank held IGC Pharma as of Q2 2026.

Based on Wealthcare Advisory Partners's 13F filing for Q2 2026, filed 9 Jul 2026.